Pharma Giant Adopts ValGenesis iClean for Digital Cleaning Validation
Event summary
- An international pharmaceutical company has selected ValGenesis iClean™ to modernize its cleaning validation operations.
- ValGenesis iClean™ streamlines cleaning process design and execution through risk-based strategies and compliant evidence capture.
- The application will support the oversight of more than a dozen active pharmaceutical ingredients.
- The implementation marks the beginning of a broader digital transformation initiative, starting at a single manufacturing site and expanding to additional sites over time.
The big picture
This partnership highlights the growing trend of pharmaceutical companies embracing digital solutions to enhance compliance and operational efficiency. The adoption of ValGenesis iClean™ reflects a broader industry shift towards digital transformation in validation processes, driven by the need for scalability and robust risk assessments. The implementation of this solution could set a precedent for other companies looking to modernize their cleaning validation operations.
What we're watching
- Execution Risk
- The pace at which the pharmaceutical company can scale the implementation of ValGenesis iClean™ across multiple manufacturing sites.
- Regulatory Compliance
- How the digitalization of cleaning validation processes will impact regulatory compliance and audits.
- Industry Trends
- Whether other pharmaceutical companies will follow suit in adopting digital solutions for cleaning validation.
Related topics
